SCHEMBL4849042

SCHEMBL4849042

CC(C)(C)c1ccccc1C(=O)c1c(N)cccc1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.45
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
CDC25B P30305 1/20 0.39
ALDH1A1 P00352 4/20 0.38
ALOX15 P16050 3/20 0.38
MYC P01106 1/20 0.38
G6PD P11413 1/20 0.38
CASP7 P55210 1/20 0.38
CASP6 P55212 1/20 0.38
LMNA P02545 1/20 0.37
TAS2R14 Q9NYV8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4865208 0.85 TAS2R14 (0.46) MMP2MAPTGAAHSD17B10KDM4E
SCHEMBL4849052 0.81 G6PD (0.47) MMP2CDC25BALDH1A1ALOX15MYC
SCHEMBL6917724 0.79 MAPT (0.66) MMP2MAPTGAAHSD17B10CDC25B
SCHEMBL10489765 0.79 GLRA3 (0.46) MMP2MAPTHSD17B10KDM4ENPC1
SCHEMBL28229430 0.79 ALDH1A1 (0.54) HSD17B10CDC25BALDH1A1ALOX15LMNA
SCHEMBL39249 0.78 ALDH1A1 (0.56) MAPTHSD17B10KDM4ECDC25BALDH1A1
SCHEMBL31028133 0.78 ALDH1A1 (0.56) MAPTHSD17B10KDM4ECDC25BALDH1A1
SCHEMBL1355526 0.77 ALOX15 (0.47) HSD17B10KDM4ECDC25BALDH1A1ALOX15
SCHEMBL31229322 0.77 ALOX15 (0.47) HSD17B10KDM4ECDC25BALDH1A1ALOX15
SCHEMBL5056823 0.76 ALDH1A1 (0.58) MMP2MAPTGAAKDM4ECDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342039-B2 Substituted indole oximes WYETH (US) 2008-03-11 US disclosed
US-20050119326-A1 Substituted aryloximes WYETH (US) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119326-A1 Substituted aryloximes IDO2, TDO2, IDO1 MMP2 2365/4885MAPT 4402/4885GAA 4099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.